Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ESTEE LAUDER COMPANIES INCEL · Entity 3097 | Director | September 15, 2021 | September 16, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ESTEE LAUDER COMPANIES INC
Report date September 15, 2021 · Filed September 16, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Units (Share Payout)SEC Table II · derivative / convertible security | Direct | 22,892.11 |
Reported balance
After 2021-09-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-09-15 · Grant · Acquired 37.12 · Balance 22,892.11 F1: Not applicable. F2: Represents reinvestment of dividend equivalents on outstanding stock units. F3: The Stock Units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. |
| Stock Units (Cash Payout)SEC Table II · derivative / convertible security | Direct | 80,015.93 |
Reported balance
After 2021-09-15 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-09-15 · Grant · Acquired 129.78 · Balance 80,015.93 F1: Not applicable. F2: Represents reinvestment of dividend equivalents on outstanding stock units. F3: The Stock Units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. |
Filing footnotes · ownership attribution and instrument terms
F1: Not applicable.
F2: Represents reinvestment of dividend equivalents on outstanding stock units.
F3: The Stock Units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ARATANA THERAPEUTICS, INC.
Report date July 18, 2019 · Filed July 18, 2019
Section 16 reporting ended · disclosed 2019-07-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-07-18 transaction · row 1
1 source rowRow 1 · 2019-07-18 · Disposition to issuer · Disposed 82,985 · Balance 0 F1: On July 18, 2019, pursuant to that certain Agreement and Plan of Merger dated April 26, 2019 (the "Merger Agreement") among Aratana Therapeutics, Inc. (the "Company"), Elanco Animal Health Incorporated ("Elanco") and Elanco Athens, Inc., a Delaware corporation and a direct wholly owned subsidiary of Elanco ("Elanco Athens"), Elanco Athens merged with and into the Company (the "Merger"), with the Company surviving as a wholly owned subsidiary of Elanco. Pursuant to the Merger Agreement, each outstanding share of Company common stock (other than certain excluded shares as described in the Merger Agreement) was converted into the right to receive (A) 0.1481 validly issued, fully paid and non-assessable shares of Elanco common stock (the "Stock Consideration"), having a market value of $4.91 on the effective date of the Merger, and (B) one contingent value right, which represents the contractual right to receive a contingent cash (continued in footnote 2) F2: (continued from footnote 1) payment of $0.25 per share of Company common stock if a specified milestone is achieved within agreed time periods, subject to and in accordance with the CVR Agreement, dated July 18, 2019, by and among Elanco, Broadridge Corporate Issuer Solutions, Inc., and UMB Bank, National Association (together with the Stock Consideration, the "Merger Consideration"). F3: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of all outstanding unvested Company restricted stock awards was accelerated in full and each such restricted stock award was cancelled and terminated as of the effective time of the Merger. Each holder of a Company restricted stock award received the right to the Merger Consideration due with respect to the shares of Company common stock received in exchange for such accelerated restricted stock awards. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.18 | Direct | 0 |
Reported balance
After 2019-07-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-07-18 · Disposition to issuer · Disposed 20,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.27 | Direct | 0 |
Reported balance
After 2019-07-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-07-18 · Disposition to issuer · Disposed 10,000 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.12 | Direct | 0 |
Reported balance
After 2019-07-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-07-18 · Disposition to issuer · Disposed 7,500 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.84 | Direct | 0 |
Reported balance
After 2019-07-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-07-18 · Disposition to issuer · Disposed 7,500 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.36 | Direct | 0 |
Reported balance
After 2019-07-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-07-18 · Disposition to issuer · Disposed 7,500 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.80 | Direct | 0 |
Reported balance
After 2019-07-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-07-18 · Disposition to issuer · Disposed 7,500 · Balance 0 F4: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares. |
Filing footnotes · ownership attribution and instrument terms
F1: On July 18, 2019, pursuant to that certain Agreement and Plan of Merger dated April 26, 2019 (the "Merger Agreement") among Aratana Therapeutics, Inc. (the "Company"), Elanco Animal Health Incorporated ("Elanco") and Elanco Athens, Inc., a Delaware corporation and a direct wholly owned subsidiary of Elanco ("Elanco Athens"), Elanco Athens merged with and into the Company (the "Merger"), with the Company surviving as a wholly owned subsidiary of Elanco. Pursuant to the Merger Agreement, each outstanding share of Company common stock (other than certain excluded shares as described in the Merger Agreement) was converted into the right to receive (A) 0.1481 validly issued, fully paid and non-assessable shares of Elanco common stock (the "Stock Consideration"), having a market value of $4.91 on the effective date of the Merger, and (B) one contingent value right, which represents the contractual right to receive a contingent cash (continued in footnote 2)
F2: (continued from footnote 1) payment of $0.25 per share of Company common stock if a specified milestone is achieved within agreed time periods, subject to and in accordance with the CVR Agreement, dated July 18, 2019, by and among Elanco, Broadridge Corporate Issuer Solutions, Inc., and UMB Bank, National Association (together with the Stock Consideration, the "Merger Consideration").
F3: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of all outstanding unvested Company restricted stock awards was accelerated in full and each such restricted stock award was cancelled and terminated as of the effective time of the Merger. Each holder of a Company restricted stock award received the right to the Merger Consideration due with respect to the shares of Company common stock received in exchange for such accelerated restricted stock awards.
F4: Pursuant to the terms of the Merger Agreement, immediately prior to the effective time of the Merger, the vesting of each outstanding Company option was accelerated in full and each such option was net exercised and immediately cancelled and terminated. Each holder of such a Company option was treated as holding the number of shares of Company common stock issuable upon exercise of the option in full multiplied by the Net Exercise Ratio (as defined in the Merger Agreement), and received the right to the Merger Consideration with respect to such shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2017 Filed Mar 16, 2017 19:59 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Cash Payout) · Derivative | 290.78 | $85.33 | $24,812.26 |
DisclosureSEC source: 0001001250-17-000021 · edgar.xml · derivative · entry 2 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,266.9 Underlying: Class A Common Stock · 290.78 shares Expires not disclosed F1 · derivative.exercise_price: Not applicable. F2 · kind: Represents reinvestment of dividend equivalents on outstanding stock units. F3 · derivative.exercise_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. F3 · derivative.expiration_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. Read SEC document |
| March 15, 2017 Filed Mar 16, 2017 19:59 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Share Payout) · Derivative | 79.48 | $85.33 | $6,782.03 |
DisclosureSEC source: 0001001250-17-000021 · edgar.xml · derivative · entry 1 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,028.85 Underlying: Class A Common Stock · 79.48 shares Expires not disclosed F1 · derivative.exercise_price: Not applicable. F2 · kind: Represents reinvestment of dividend equivalents on outstanding stock units. F3 · derivative.exercise_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. F3 · derivative.expiration_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 22:36 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Cash Payout) · Derivative | 262.52 | $82.85 | $21,749.78 |
DisclosureSEC source: 0001001250-17-000012 · edgar.xml · derivative · entry 1 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,976.12 Underlying: Class A Common Stock · 262.52 shares Expires not disclosed F1 · derivative.exercise_price: Each Stock Unit (cash payout) is convertible into cash equal to the value of one share of Class A Common Stock (i.e. 1:1). F2 · kind: Represents grant of Stock Units in lieu of cash for quarterly board and committee retainers. F3 · derivative.exercise_date: The Stock Units (cash payout) will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the Company. F3 · derivative.expiration_date: The Stock Units (cash payout) will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the Company. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 19:04 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | SaleClass A Common Stock | 3,300 | $85.02 | $280,566.00 |
DisclosureSEC source: 0001001250-17-000007 · edgar.xml · nonDerivative · entry 1 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,240 F1 · price: The number of securities reported represents an aggregate number of shares sold in multiple open market transactions over a range of sales prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range. F2 · price: Sales price range from $84.98 to $85.14 per share, inclusive. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 16:30 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Cash Payout) · Derivative | 317.28 | $77.58 | $24,614.58 |
DisclosureSEC source: 0001001250-16-000267 · edgar.xml · derivative · entry 2 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,713.6 Underlying: Class A Common Stock · 317.28 shares Expires not disclosed F1 · derivative.exercise_price: Not applicable. F2 · kind: Represents reinvestment of dividend equivalents on outstanding stock units. F3 · derivative.exercise_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. F3 · derivative.expiration_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 16:30 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Share Payout) · Derivative | 87.04 | $77.58 | $6,752.56 |
DisclosureSEC source: 0001001250-16-000267 · edgar.xml · derivative · entry 1 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,949.37 Underlying: Class A Common Stock · 87.04 shares Expires not disclosed F1 · derivative.exercise_price: Not applicable. F2 · kind: Represents reinvestment of dividend equivalents on outstanding stock units. F3 · derivative.exercise_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. F3 · derivative.expiration_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:35 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Cash Payout) · Derivative | 596.6 | $78.36 | $46,749.58 |
DisclosureSEC source: 0001001250-16-000253 · edgar.xml · derivative · entry 3 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,396.32 Underlying: Class A Common Stock · 596.6 shares Expires not disclosed F4 · derivative.exercise_price: Each stock unit (cash payout) is convertible into cash equal to the value of one share of Class A Common Stock (i.e. 1:1). F5 · kind: Reflects grant of stock units in lieu of cash for quarterly board and committee retainers, as well as annual chairmanship fee. F6 · derivative.exercise_date: The stock units (cash payout) will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the Company. F6 · derivative.expiration_date: The stock units (cash payout) will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the Company. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:35 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Share Payout) · Derivative | 889.18 | $0.00 | $0.00 |
DisclosureSEC source: 0001001250-16-000253 · edgar.xml · derivative · entry 2 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,862.33 Underlying: Class A Common Stock · 889.18 shares Expires not disclosed F2 · derivative.exercise_price: Each stock unit (share payout) is convertible into one share of Class A Common Stock (i.e. 1:1). F1 · kind: Granted pursuant to the Issuer's Amended and Restated Non-Employee Director Share Incentive Plan. F3 · derivative.exercise_date: The stock units (share payout) will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the Company. F3 · derivative.expiration_date: The stock units (share payout) will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the Company. Read SEC document |
| November 11, 2016 Filed Nov 14, 2016 22:35 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantOption (Right to Buy) · Derivative | 4,697 | $0.00 Strike: $78.36 | $0.00 |
DisclosureSEC source: 0001001250-16-000253 · edgar.xml · derivative · entry 1 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,697 Underlying: Class A Common Stock · 4,697 shares Expires 2026-11-11 F1 · kind: Granted pursuant to the Issuer's Amended and Restated Non-Employee Director Share Incentive Plan. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:30 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Cash Payout) · Derivative | 244.33 | $87.86 | $21,466.83 |
DisclosureSEC source: 0001001250-16-000232 · edgar.xml · derivative · entry 2 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,799.72 Underlying: Class A Common Stock · 244.33 shares Expires not disclosed F1 · derivative.exercise_price: Not applicable. F2 · kind: Represents reinvestment of dividend equivalents on outstanding stock units. F3 · derivative.exercise_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. F3 · derivative.expiration_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. Read SEC document |
| September 15, 2016 Filed Sep 16, 2016 19:30 UTC | ESTEE LAUDER COMPANIES INC EL · Entity 3097 | GrantStock Units (Share Payout) · Derivative | 64.56 | $87.86 | $5,672.24 |
DisclosureSEC source: 0001001250-16-000232 · edgar.xml · derivative · entry 1 Hockaday Irvine O Jr · CIK 0001113487 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,973.15 Underlying: Class A Common Stock · 64.56 shares Expires not disclosed F1 · derivative.exercise_price: Not applicable. F2 · kind: Represents reinvestment of dividend equivalents on outstanding stock units. F3 · derivative.exercise_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. F3 · derivative.expiration_date: The stock units will be paid out the first business day of the calendar year following the last date of the Reporting Person's service as a director of the company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.